Calmodulin and HIV type 1: Interactions with Gag and Gag products

AIDS Research and Human Retroviruses

Volumn 16, Issue 15, 2000, Pages 1519-1525

  Radding, W ^a   Williams, J P ^b   McKenna, M A ^b   Tummala, R ^c   Hunter, E ^d   Tytler, E M ^d   McDonald, J M ^b  

^a RICE UNIVERSITY   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALMODULIN; EGTAZIC ACID; GAG PROTEIN; HYBRID PROTEIN; PROTEIN P17; PROTEIN P55; TRYPTOPHAN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIGENICITY; ARTICLE; BINDING SITE; CELL METABOLISM; DISSOCIATION; FLUOROMETRY; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; STOICHIOMETRY;

AMINO ACID SEQUENCE; BINDING SITES; CALCIUM; CALMODULIN; CELL LINE; GENE PRODUCTS, GAG; HIV ANTIGENS; HIV CORE PROTEIN P24; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN PRECURSORS; RECOMBINANT FUSION PROTEINS; VIRAL PROTEINS;

EID: 0034633610     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/088922200750006047     Document Type: Article

References (33)

1. Cytosolic domain of the human immunodeficiency virus envelope and glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins
2. Identification of a calmodulin-binding and inhibitory peptide domain in the HIV-1 transmembrane glycoprotein
3. Interruption of T-cell signal transduction by lentivirus lytic peptides from HIV-1 transmembrane protein
4. Apoptosis induction by the binding of the carboxyl terminus of human immunodeficiency virus type 1 gp160 to calmodulin
5. Requirement of calmodulin binding to HIV-1 gp160 for enhanced Fas-mediated apoptosis
6. Expression of HIV-1 envelope glycoprotein alters cellular calmodulin
7. Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity
8. Monoclonal antibody to calmodulin: Development, characterization, and comparison with polyclonal anti-calmodulin antibodies
9. 125I-labeled protein gel overlay technique to study calmodulin-binding proteins
10. Amphipathic helix motif: Classes and properties
11. Crystal structures of the trimeric human immuno-deficiency virus type 1 matrix protein: Implications for membrane association and assembly
12. Studies of calcineurin-calmodulin interaction: Probing the role of arginine residues using peptidylarginine deiminase
13. Real-time-analysis of the calcium-dependent interaction between calmodulin and a synthetic oligopeptide of calcineurin by a surface plasmon resonance behavior biosensor
14. Calmodulin
15. The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions
16. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix
17. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions
18. Solution structure of a calmodulin-target peptide complex by multidimensional NMR
19. Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17
20. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein
21. Characterization of the calmodulin-binding sites of muscle phosphofructokinase and comparison with known calmodulin-binding domains
22. Amino acid sequence of rabbit skeletal muscle myosin light chain kinase
23. Identification of a membrane-binding domain within the amino-terminal region of human immunodeficieincy virus type 1 Gag protein which interacts with acidic phospholipids
24. Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA
25. Opposing effects of human immunodeficiency virus type 1 matrix mutations support a myristyl switch model of Gag membrane targeting
26. Determinants of calcineurin binding to model membranes
27. MARCKS, membranes, and calmodulin: Kinetics of their interaction
28. Interaction of calmodulin-binding domain peptides of nitric oxide synthase with membrane phospholipids: Regulation by protein phosphorylation and Ca(2+)-calmodulin
29. Absconding with the chaperone: Essential cyclophilin-Gag interaction in HIV-1 virions
30. HIV protease substrate conformation: Modulation by cyclophilin A
31. Role of cyclophilin A in the uptake of HIV-1 by macrophages and T lymphocytes
32. Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin A